Key Client Fiduciary Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$875K Buy
8,454
+287
+4% +$25.6K 0.25% 82
2026
Q1
$587K Buy
8,167
+228
+3% +$17.6K 0.2% 108
2025
Q4
$630K Sell
7,939
-30
-0.4% -$2.37K 0.21% 98
2025
Q3
$601K Buy
7,969
+178
+2% +$12.2K 0.2% 100
2025
Q2
$537K Buy
7,791
+695
+10% +$45.6K 0.22% 105
2025
Q1
$481K Buy
7,096
+96
+1% +$5.75K 0.22% 105
2024
Q4
$314K Sell
7,000
-182
-3% -$10.2K 0.14% 144
2024
Q3
$452K Buy
7,182
+795
+12% +$46.4K 0.2% 107
2024
Q2
$377K Sell
6,387
-94
-1% -$5.88K 0.19% 115
2024
Q1
$517K Sell
6,481
-25
-0.4% -$1.91K 0.27% 83
2023
Q4
$514K Buy
6,506
+314
+5% +$22.3K 0.3% 83
2023
Q3
$432K Buy
6,192
+854
+16% +$60.5K 0.27% 93
2023
Q2
$369K Buy
5,338
+987
+23% +$70.2K 0.21% 110
2023
Q1
$323K Buy
4,351
+174
+4% +$14.6K 0.2% 113
2022
Q4
$389K Buy
4,177
+772
+23% +$74.5K 0.26% 89
2022
Q3
$325K Sell
3,405
-491
-13% -$48.6K 0.29% 74
2022
Q2
$361K Buy
3,896
+197
+5% +$19.2K 0.35% 66
2022
Q1
$374K Sell
3,699
-152
-4% -$16K 0.3% 84
2021
Q4
$397K Buy
+3,851
New +$356K 0.33% 73

Other funds holding CVS

Key Client Fiduciary Advisors's CVS Position: Q2 2026 in Review

Key Client Fiduciary Advisors increased its CVS Health (CVS) stake by 3.5% in Q2 2026, buying an estimated $25.6K and bringing the position to 8,454 shares worth $875K. The position accounts for 0.25% of the portfolio, ranked #82.

Key Client Fiduciary Advisors first reported a position in CVS in Q4 2021 and has held it in 19 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Key Client Fiduciary Advisors held 8,454 shares of CVS Health worth $875K as of Q2 2026.
  • Key Client Fiduciary Advisors bought 287 CVS Health shares in Q2 2026, an estimated $25.6K.
  • CVS Health made up 0.25% of Key Client Fiduciary Advisors's portfolio in Q2 2026, its #82 holding.
  • Key Client Fiduciary Advisors first reported a position in CVS Health in Q4 2021 and has held it in 19 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Key Client Fiduciary Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.